InfectionPub Date : 2024-08-22DOI: 10.1007/s15010-024-02373-z
Natasja van de Pol, C Janneke van der Woude, Marijn Vis, Martijn B A van Doorn, Saskia L Schrauwen, Fatos Cetinözman-Teunissen, Rachel L West, Annemarie C de Vries
{"title":"Patients with immune mediated inflammatory diseases are insufficiently protected against vaccine-preventable infections.","authors":"Natasja van de Pol, C Janneke van der Woude, Marijn Vis, Martijn B A van Doorn, Saskia L Schrauwen, Fatos Cetinözman-Teunissen, Rachel L West, Annemarie C de Vries","doi":"10.1007/s15010-024-02373-z","DOIUrl":"https://doi.org/10.1007/s15010-024-02373-z","url":null,"abstract":"<p><strong>Background: </strong>Patients with Immune Mediated Inflammatory Diseases (IMIDs) using immunosuppressive therapy are at increased risk of infections, including vaccine-preventable infections. In this study, we aimed to evaluate whether patients with IMIDs on systemic immunosuppressive therapy are vaccinated according to current guidelines.</p><p><strong>Methods: </strong>A survey was sent out, between August 2022 and March 2023, to all patients with IMIDs that visited the departments of dermatology, rheumatology and gastroenterology at an academic and regional hospital in Rotterdam, the Netherlands. Patient-reported vaccination status was compared to the Dutch guidelines on vaccinations in patients with chronic inflammatory diseases.</p><p><strong>Results: </strong>A total of 1,905/5,987 patients responded to the survey (response rate 32%). After exclusion of patients without systemic immunosuppressive medication, the study population comprised 1,390 patients, median age 56 years (IQR 42-66) and 41% male. Most patients (92%) had been vaccinated according to the Dutch National Immunization Program. Before starting immunosuppressive therapy, 2% of the patients who were still considered at risk according to the Dutch guideline were vaccinated for measles, and 4% for diphtheria/tetanus/polio (DT-IPV). Additionally, 62% of patients received an annual influenza vaccine, 16% received a five-yearly pneumococcal vaccine, and 91% were fully vaccinated against COVID-19.</p><p><strong>Conclusion: </strong>Patients with IMIDs on immunosuppressive therapy are not vaccinated in accordance with the guidelines. Implementation strategies to improve the vaccination rates for patients with IMIDs should specifically focus on vaccinating against measles and diphtheria/tetanus/polio, and periodic vaccination against pneumococcal and influenza infections.</p>","PeriodicalId":13600,"journal":{"name":"Infection","volume":" ","pages":""},"PeriodicalIF":5.4,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142017388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
InfectionPub Date : 2024-08-19DOI: 10.1007/s15010-024-02369-9
Annika P Schnell
{"title":"No antibiotics for asymptomatic bacteriuria.","authors":"Annika P Schnell","doi":"10.1007/s15010-024-02369-9","DOIUrl":"https://doi.org/10.1007/s15010-024-02369-9","url":null,"abstract":"","PeriodicalId":13600,"journal":{"name":"Infection","volume":" ","pages":""},"PeriodicalIF":5.4,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142004124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
InfectionPub Date : 2024-08-16DOI: 10.1007/s15010-024-02362-2
Lene T Tscharntke, Norma Jung, Frank Hanses, Carolin E M Koll, Lisa Pilgram, Siegbert Rieg, Stefan Borgmann, Susana M Nunes de Miranda, Margarete Scherer, Christoph D Spinner, Maria Rüthrich, Maria J G T Vehreschild, Michael von Bergwelt-Baildon, Kai Wille, Uta Merle, Martin Hower, Katja Rothfuss, Silvio Nadalin, Hartwig Klinker, Julia Fürst, Ingo Greiffendorf, Claudia Raichle, Anette Friedrichs, Dominic Rauschning, Katja de With, Lukas Eberwein, Christian Riedel, Milena Milovanovic, Maximilian Worm, Beate Schultheis, Jörg Schubert, Marc Bota, Gernot Beutel, Thomas Glück, Michael Schmid, Tobias Wintermantel, Helga Peetz, Stephan Steiner, Elena Ribel, Harald Schäfer, Jörg Janne Vehreschild, Melanie Stecher
{"title":"Role and benefits of infectious diseases specialists in the COVID-19 pandemic: Multilevel analysis of care provision in German hospitals using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS) cohort.","authors":"Lene T Tscharntke, Norma Jung, Frank Hanses, Carolin E M Koll, Lisa Pilgram, Siegbert Rieg, Stefan Borgmann, Susana M Nunes de Miranda, Margarete Scherer, Christoph D Spinner, Maria Rüthrich, Maria J G T Vehreschild, Michael von Bergwelt-Baildon, Kai Wille, Uta Merle, Martin Hower, Katja Rothfuss, Silvio Nadalin, Hartwig Klinker, Julia Fürst, Ingo Greiffendorf, Claudia Raichle, Anette Friedrichs, Dominic Rauschning, Katja de With, Lukas Eberwein, Christian Riedel, Milena Milovanovic, Maximilian Worm, Beate Schultheis, Jörg Schubert, Marc Bota, Gernot Beutel, Thomas Glück, Michael Schmid, Tobias Wintermantel, Helga Peetz, Stephan Steiner, Elena Ribel, Harald Schäfer, Jörg Janne Vehreschild, Melanie Stecher","doi":"10.1007/s15010-024-02362-2","DOIUrl":"https://doi.org/10.1007/s15010-024-02362-2","url":null,"abstract":"<p><strong>Purpose: </strong>This study investigates the care provision and the role of infectious disease (ID) specialists during the coronavirus disease-2019 (COVID-19) pandemic.</p><p><strong>Methods: </strong>A survey was conducted at German study sites participating in the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS). Hospitals certified by the German Society of Infectious diseases (DGI) were identified as ID centers. We compared care provision and the involvement of ID specialists between ID and non-ID hospitals. Then we applied a multivariable regression model to analyse how clinical ID care influenced the mortality of COVID-19 patients in the LEOSS cohort.</p><p><strong>Results: </strong>Of the 40 participating hospitals in the study, 35% (14/40) were identified as ID centers. Among those, clinical ID care structures were more commonly established, and ID specialists were always involved in pandemic management and the care of COVID-19 patients. Overall, 68% (27/40) of the hospitals involved ID specialists in the crisis management team, 78% (31/40) in normal inpatient care, and 80% (28/35) in intensive care. Multivariable analysis revealed that COVID-19 patients in ID centers had a lower mortality risk compared to those in non-ID centers (odds ratio: 0.61 (95% CI 0.40-0.93), p = 0.021).</p><p><strong>Conclusion: </strong>ID specialists played a crucial role in pandemic management and inpatient care.</p>","PeriodicalId":13600,"journal":{"name":"Infection","volume":" ","pages":""},"PeriodicalIF":5.4,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141987863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
InfectionPub Date : 2024-08-16DOI: 10.1007/s15010-024-02360-4
Jingyuan Chen, Zhen Qin, Zhongwei Jia
{"title":"The application status of sequencing technology in global respiratory infectious disease diagnosis.","authors":"Jingyuan Chen, Zhen Qin, Zhongwei Jia","doi":"10.1007/s15010-024-02360-4","DOIUrl":"https://doi.org/10.1007/s15010-024-02360-4","url":null,"abstract":"<p><p>Next-generation sequencing (NGS) has revolutionized clinical microbiology, particularly in diagnosing respiratory infectious diseases and conducting epidemiological investigations. This narrative review summarizes conventional methods for routine respiratory infection diagnosis, including culture, smear microscopy, immunological assays, image techniques as well as polymerase chain reaction(PCR). In contrast to conventional methods, there is a new detection technology, sequencing technology, and here we mainly focus on the next-generation sequencing NGS, especially metagenomic NGS(mNGS). NGS offers significant advantages over traditional methods. Firstly, mNGS eliminates assumptions about pathogens, leading to faster and more accurate results, thus reducing diagnostic time. Secondly, it allows unbiased identification of known and novel pathogens, offering broad-spectrum coverage. Thirdly, mNGS not only identifies pathogens but also characterizes microbiomes, analyzes human host responses, and detects resistance genes and virulence factors. It can complement targeted sequencing for bacterial and fungal classification. Unlike traditional methods affected by antibiotics, mNGS is less influenced due to the extended survival of pathogen DNA in plasma, broadening its applicability. However, barriers to full integration into clinical practice persist, primarily due to cost constraints and limitations in sensitivity and turnaround time. Despite these challenges, ongoing advancements aim to improve cost-effectiveness and efficiency, making NGS a cornerstone technology for global respiratory infection diagnosis.</p>","PeriodicalId":13600,"journal":{"name":"Infection","volume":" ","pages":""},"PeriodicalIF":5.4,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141995668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
InfectionPub Date : 2024-08-16DOI: 10.1007/s15010-024-02315-9
Irene Bianconi, Laura Battisti, Alex Staffler, Elisabetta Giacobazzi, Elisa Masi, Elisabetta Incrocci, Marion Bellutti, Stefano Fontana, Paola Stefanelli, Gabriele Buttinelli, Elisabetta Pagani
{"title":"Disseminated Echovirus 11 infection in a newborn in the Province of Bolzano, Italy.","authors":"Irene Bianconi, Laura Battisti, Alex Staffler, Elisabetta Giacobazzi, Elisa Masi, Elisabetta Incrocci, Marion Bellutti, Stefano Fontana, Paola Stefanelli, Gabriele Buttinelli, Elisabetta Pagani","doi":"10.1007/s15010-024-02315-9","DOIUrl":"https://doi.org/10.1007/s15010-024-02315-9","url":null,"abstract":"<p><strong>Purpose: </strong>Recently, cases of serious illness in newborns infected with Echovirus 11 have been reported in Europe, including Italy. Here, we report the case of a newborn diagnosed with disseminated Echovirus 11 infection, which occurred in October 2023 in the Province of Bolzano, Italy.</p><p><strong>Methods: </strong>A molecular screening, by Real-Time RT-PCR, was employed to analyse the cerebrospinal fluid, blood and stool samples, and nasal swabs. The entire viral genome was sequenced using both Illumina and Nanopore technologies.</p><p><strong>Results: </strong>The patient was admitted to hospital due to fever. Molecular testing revealed the presence of enterovirus RNA. Typing confirmed the presence of Echovirus 11. The patient was initially treated with antibiotic therapy and, following the diagnosis of enterovirus infection, also with human immunoglobulins. Over the following days, the patient remained afebrile, with decreasing inflammation indices and in excellent general condition. Genomic and phylogenetic characterization suggested that the strain was similar to strains from severe cases reported in Europe.</p><p><strong>Conclusions: </strong>Despite the low overall risk for the neonatal population in Europe, recent cases of Echovirus 11 have highlighted the importance of surveillance and complete genome sequencing is fundamental to understanding the phylogenetic relationships of Echovirus 11 variants.</p>","PeriodicalId":13600,"journal":{"name":"Infection","volume":" ","pages":""},"PeriodicalIF":5.4,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141987862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Alzheimer's disease following COVID-19: a two player match?","authors":"Raffaella Mormile, Cristina Mormile, Carmine Picone","doi":"10.1007/s15010-024-02368-w","DOIUrl":"https://doi.org/10.1007/s15010-024-02368-w","url":null,"abstract":"<p><p>Common pathways may underlie the association between COVID-19 and risk for Alzheimer's disease (AD). We conjecture that severe COVID-19 may contribute to AD onset in predisposed individuals through aberrant MDSCs expression and increased IL-6 expression levels leading to immunosuppression in inflamed brains. Research studies are needed to gain empirical evidence to strengthen the hypothesis of the involvement of MDSCs and IL-6 in the formation of AD following COVID-19 infection and possibly vaccination enabling a more in-depth understanding of the role of immunosuppression in the onset of neurodegenerative diseases at any age. Identifying why those who get severe COVID-19 are more likely to develop AD may offer a novel therapeutic approach to delay or prevent cognitive decline.</p>","PeriodicalId":13600,"journal":{"name":"Infection","volume":" ","pages":""},"PeriodicalIF":5.4,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141982235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"High prevalence of polymyxin-heteroresistant carbapenem-resistant Klebsiella pneumoniae and its within-host evolution to resistance among critically ill scenarios.","authors":"Xiaoli Wang, Tianjiao Meng, Yunqi Dai, Hong-Yu Ou, Meng Wang, Bin Tang, Jingyong Sun, Decui Cheng, Tingting Pan, Ruoming Tan, Hongping Qu","doi":"10.1007/s15010-024-02365-z","DOIUrl":"https://doi.org/10.1007/s15010-024-02365-z","url":null,"abstract":"<p><strong>Purpose: </strong>We aimed to explore the prevalence and within-host evolution of resistance in polymyxin-heteroresistant carbapenem-resistant Klebsiella pneumoniae (PHR-CRKP) in critically ill patients.</p><p><strong>Methods: </strong>We performed an epidemiological analysis of consecutive patients with PHR-CRKP from clinical cases. Our study investigated the within-host resistance evolution and its clinical significance during polymyxin exposure. Furthermore, we explored the mechanisms underlying the dynamic evolution of polymyxin resistance at both subpopulation and genetic levels, involved population analysis profile test, time-killing assays, competition experiments, and sanger sequencing. Additionally, comparative genomic analysis was performed on 713 carbapenemase-producing K. pneumoniae strains.</p><p><strong>Results: </strong>We enrolled 109 consecutive patients, and PHR-CRKP was found in 69.7% of patients without previous polymyxin exposure. 38.1% of PHR-CRKP isolates exhibited polymyxin resistance and led to therapeutic failure in critically ill scenarios. An increased frequency of resistant subpopulations was detected during PHR-CRKP evolution, with rapid regrowth of resistant subpopulations under high polymyxin concentrations, and a fitness cost in an antibiotic-free environment. Mechanistic analysis revealed that diverse mgrB insertions and pmrB hypermutations contributed to the dynamic changes in polymyxin susceptibility in dominant resistant subpopulations during PHR evolution, which were validated by comparative genomic analysis. Several deleterious mutations (e.g. pmrB<sup>Leu82Arg</sup>, pmrB<sup>Ser85Arg</sup>) were firstly detected during PHR-CRKP evolution. Indeed, specific sequence types of K. pneumoniae demonstrated unique deletions and deleterious mutations.</p><p><strong>Conclusions: </strong>Our study emphasizes the high prevalence of pre-existing heteroresistance in CRKP, which can lead to polymyxin resistance and fatal outcomes. Hence, it is essential to continuously monitor and observe the treatment response to polymyxins in appropriate critically ill scenarios.</p>","PeriodicalId":13600,"journal":{"name":"Infection","volume":" ","pages":""},"PeriodicalIF":5.4,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141982238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
InfectionPub Date : 2024-08-14DOI: 10.1007/s15010-024-02361-3
Moritz Hafkesbrink, M Schemmerer, J J Wenzel, S Isenmann
{"title":"Acute hepatitis E virus infection presenting as meningo-encephalitis.","authors":"Moritz Hafkesbrink, M Schemmerer, J J Wenzel, S Isenmann","doi":"10.1007/s15010-024-02361-3","DOIUrl":"https://doi.org/10.1007/s15010-024-02361-3","url":null,"abstract":"<p><strong>Background: </strong>Acute hepatitis E infection (HEV), with its high incidence in Europe, should be considered as a differential diagnosis of acute viral hepatitis and can in some cases manifest with pronounced neurological symptoms.</p><p><strong>Clinical case: </strong>We report on a 33-year-old female patient with severe arthralgia, myalgia, headache and psychomotor deterioration. Laboratory analyses showed elevated transaminases without signs of cholestasis. Acute hepatitis E virus infection was detected in serum. She reported fatigue and dysesthesias not responsive to analgesics. Cerebrospinal fluid (CSF) analysis revealed an inflammatory syndrome. HEV RNA was detected in the CSF. The infection remained mild, but dysesthesias persisted. Eight weeks after the first admission, the symptoms worsened again. Complete and sustained remission was achieved following intravenous corticosteroid treatment.</p><p><strong>Conclusion: </strong>In patients with acute neurological symptoms and liver enzyme elevation, HEV infection should be considered. Neurologic symptoms such as fatigue, arthralgia, myalgia and dysesthesia along with psychomotor retardation should prompt CSF analysis.</p>","PeriodicalId":13600,"journal":{"name":"Infection","volume":" ","pages":""},"PeriodicalIF":5.4,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141982234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
InfectionPub Date : 2024-08-14DOI: 10.1007/s15010-024-02345-3
Elie Azoulay, Olivier Lescale
{"title":"Contemplating dengue: the thinker's reflection on symptoms.","authors":"Elie Azoulay, Olivier Lescale","doi":"10.1007/s15010-024-02345-3","DOIUrl":"https://doi.org/10.1007/s15010-024-02345-3","url":null,"abstract":"<p><p>In this image, the autors reinterprate \"The Thinker\" from Auguste Rodin to transfer knowledge about dengue fever, which can range from flu-like illness to severe hemorrhagic fever. By fostering awareness and understanding of dengue fever, we strive to empower individuals and communities in the ongoing fight against dengue and other infectious threats.</p>","PeriodicalId":13600,"journal":{"name":"Infection","volume":" ","pages":""},"PeriodicalIF":5.4,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141982236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}